Cargando…

COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy

BACKGROUND: COVID-19 myocarditis occurs in 7–28% of patients admitted in the hospital with or without multisystem inflammatory syndrome. It may present as fulminant myocarditis. Dilated cardiomyopathy as a sequela of COVID-19 myocarditis has been reported in the pediatric population. However, to dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Malakan Rad, Elaheh, Momtazmanesh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152834/
https://www.ncbi.nlm.nih.gov/pubmed/35639214
http://dx.doi.org/10.1186/s43044-022-00282-w
_version_ 1784717721210978304
author Malakan Rad, Elaheh
Momtazmanesh, Sara
author_facet Malakan Rad, Elaheh
Momtazmanesh, Sara
author_sort Malakan Rad, Elaheh
collection PubMed
description BACKGROUND: COVID-19 myocarditis occurs in 7–28% of patients admitted in the hospital with or without multisystem inflammatory syndrome. It may present as fulminant myocarditis. Dilated cardiomyopathy as a sequela of COVID-19 myocarditis has been reported in the pediatric population. However, to date, no case of silent COVID-19 myocarditis progressing to dilated cardiomyopathy has been reported in children. Furthermore, although newly developed hypertension as a sequela of COVID-19 infection has been reported in adults, there is no report of newly developed COVID-induced hypertension in children. We report a 3-year-old boy with silent COVID-19 myocarditis progressing to dilated cardiomyopathy and newly developed systemic hypertension. CASE PRESENTATION: A 3-year-old boy was referred to the emergency department because of respiratory distress. The parents gave a history of SARS-CoV-2 infection in the child 5 months ago that was manifested as fever and cough, for which he was treated as an outpatient. Echocardiographic examination revealed a severe decrease in left ventricular systolic function in favor of dilated cardiomyopathy. Cardiac magnetic resonance imaging established the diagnosis of myocarditis. The patient left ventricular systolic function did not improve after 2 weeks of intravenous inotropic support. Therefore, the child was transferred to another tertiary center with extracorporeal membrane oxygenation and pediatric cardiac transplantation facilities. CONCLUSIONS: COVID-19 can induce silent myocarditis with progression to dilated cardiomyopathy and newly developed systemic hypertension. Thus, a thorough examination of the heart and measurement of blood pressure are mandatory in every child with COVID-19 infection. Cardiac MR is an indispensable tool in the diagnosis, follow-up, and prognostication of COVID-19 myocarditis. Moreover, four-chamber speckle tracking strain imaging showed apical rocking in all the four heart chambers in this child with opposite direction in the failed left ventricle compared with other cardiac chambers. Lastly, the presence of septal flash on M-mode echocardiography, apical rocking and prestretch–rebound stretch patterns on longitudinal strain imaging of the failed left ventricle in this child may be of predictive value for response to cardiac resynchronization therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43044-022-00282-w.
format Online
Article
Text
id pubmed-9152834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91528342022-06-02 COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy Malakan Rad, Elaheh Momtazmanesh, Sara Egypt Heart J Case Report BACKGROUND: COVID-19 myocarditis occurs in 7–28% of patients admitted in the hospital with or without multisystem inflammatory syndrome. It may present as fulminant myocarditis. Dilated cardiomyopathy as a sequela of COVID-19 myocarditis has been reported in the pediatric population. However, to date, no case of silent COVID-19 myocarditis progressing to dilated cardiomyopathy has been reported in children. Furthermore, although newly developed hypertension as a sequela of COVID-19 infection has been reported in adults, there is no report of newly developed COVID-induced hypertension in children. We report a 3-year-old boy with silent COVID-19 myocarditis progressing to dilated cardiomyopathy and newly developed systemic hypertension. CASE PRESENTATION: A 3-year-old boy was referred to the emergency department because of respiratory distress. The parents gave a history of SARS-CoV-2 infection in the child 5 months ago that was manifested as fever and cough, for which he was treated as an outpatient. Echocardiographic examination revealed a severe decrease in left ventricular systolic function in favor of dilated cardiomyopathy. Cardiac magnetic resonance imaging established the diagnosis of myocarditis. The patient left ventricular systolic function did not improve after 2 weeks of intravenous inotropic support. Therefore, the child was transferred to another tertiary center with extracorporeal membrane oxygenation and pediatric cardiac transplantation facilities. CONCLUSIONS: COVID-19 can induce silent myocarditis with progression to dilated cardiomyopathy and newly developed systemic hypertension. Thus, a thorough examination of the heart and measurement of blood pressure are mandatory in every child with COVID-19 infection. Cardiac MR is an indispensable tool in the diagnosis, follow-up, and prognostication of COVID-19 myocarditis. Moreover, four-chamber speckle tracking strain imaging showed apical rocking in all the four heart chambers in this child with opposite direction in the failed left ventricle compared with other cardiac chambers. Lastly, the presence of septal flash on M-mode echocardiography, apical rocking and prestretch–rebound stretch patterns on longitudinal strain imaging of the failed left ventricle in this child may be of predictive value for response to cardiac resynchronization therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43044-022-00282-w. Springer Berlin Heidelberg 2022-05-31 /pmc/articles/PMC9152834/ /pubmed/35639214 http://dx.doi.org/10.1186/s43044-022-00282-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Malakan Rad, Elaheh
Momtazmanesh, Sara
COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
title COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
title_full COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
title_fullStr COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
title_full_unstemmed COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
title_short COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
title_sort covid-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152834/
https://www.ncbi.nlm.nih.gov/pubmed/35639214
http://dx.doi.org/10.1186/s43044-022-00282-w
work_keys_str_mv AT malakanradelaheh covid19inducedsilentmyocarditisandnewlydevelopedhypertensionina3yearoldboy
AT momtazmaneshsara covid19inducedsilentmyocarditisandnewlydevelopedhypertensionina3yearoldboy